Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE).
BRAF mutation
RAS mutation
colorectal cancer (CRC)
colorectal liver metastases (CRLM)
local tumor progression
microsatellite instability (MSI)
microwave ablation (MWA)
primary tumor sidedness
radiofrequency ablation (RFA)
surgery
thermal ablation
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
05 Aug 2021
05 Aug 2021
Historique:
received:
29
06
2021
revised:
16
07
2021
accepted:
03
08
2021
entrez:
27
8
2021
pubmed:
28
8
2021
medline:
28
8
2021
Statut:
epublish
Résumé
The aim of this study was to assess primary tumor sidedness of colorectal cancer (CRC), rat sarcoma viral oncogene homolog (RAS) and v-raf murine sarcoma viral oncogene homolog B (BRAF) mutations and microsatellite instability (MSI) status as prognostic factors predicting complications, survival outcomes, and local tumor progression (LTP) following surgery and thermal ablation in patients with colorectal liver metastases (CRLM). This Amsterdam Colorectal Liver Met Registry (AmCORE) based study included 520 patients, 774 procedures, and 2101 tumors undergoing local treatment (resection and/or thermal ablation) from 2000 to 2021. Outcomes following local treatment were analyzed for primary tumor sidedness of CRC, RAS, and BRAF mutations and MSI status. The Kaplan-Meier method was used to estimate local tumor progression-free survival (LTPFS), local control (LC), distant progression-free survival (DPFS), and overall survival (OS). Uni- and multivariable analyses were performed based on Cox proportional hazards model. The chi-square test was used to analyze complications. Complications (
Identifiants
pubmed: 34440165
pii: biomedicines9080962
doi: 10.3390/biomedicines9080962
pmc: PMC8395017
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ann Transl Med. 2020 Nov;8(21):1448
pubmed: 33313193
BMC Cancer. 2018 Jan 15;18(1):78
pubmed: 29334918
Ann Surg Oncol. 2020 Apr;27(4):1164-1173
pubmed: 31720935
Cardiovasc Intervent Radiol. 2013 Feb;36(1):166-75
pubmed: 22535243
Cardiovasc Intervent Radiol. 2018 Aug;41(8):1189-1204
pubmed: 29666906
Tech Vasc Interv Radiol. 2020 Jun;23(2):100672
pubmed: 32591188
Ann Surg. 1984 May;199(5):502-8
pubmed: 6721600
JAMA Oncol. 2016 May 1;2(5):643-653
pubmed: 26768652
Ann Surg. 2007 Aug;246(2):295-300
pubmed: 17667509
J Vasc Interv Radiol. 2011 Jun;22(6):755-61
pubmed: 21514841
Cardiovasc Intervent Radiol. 2010 Feb;33(1):11-7
pubmed: 19924474
Can Assoc Radiol J. 2018 Feb;69(1):51-62
pubmed: 29458955
Ann Surg. 2013 Oct;258(4):619-26; discussion 626-7
pubmed: 24018645
Lancet. 1994 Jun 4;343(8910):1405-10
pubmed: 7515134
Br J Surg. 2015 Sep;102(10):1175-83
pubmed: 26206254
Ann Surg. 2019 Jan;269(1):120-126
pubmed: 28549012
World J Surg Oncol. 2020 May 18;18(1):98
pubmed: 32423450
Ann Surg. 1999 Sep;230(3):309-18; discussion 318-21
pubmed: 10493478
Br J Surg. 1990 Nov;77(11):1241-6
pubmed: 2253003
Ann Surg. 2004 Jun;239(6):818-25; discussion 825-7
pubmed: 15166961
J Vasc Interv Radiol. 2015 Apr;26(4):583-7.e1
pubmed: 25805540
BMC Cancer. 2018 Aug 15;18(1):821
pubmed: 30111304
World J Clin Cases. 2020 Apr 26;8(8):1424-1443
pubmed: 32368535
Eur J Surg Oncol. 2018 Jan;44(1):80-86
pubmed: 29183640
Radiology. 2016 Feb;278(2):601-11
pubmed: 26267832
PLoS One. 2019 May 31;14(5):e0217411
pubmed: 31150437
Ann Surg Oncol. 2018 Feb;25(2):431-438
pubmed: 29181680
Cardiovasc Intervent Radiol. 2018 Jun;41(6):912-919
pubmed: 29582125
Br J Surg. 2017 May;104(6):760-768
pubmed: 28240361
Oncotarget. 2017 Aug 2;8(39):66117-66127
pubmed: 29029497
Eur Radiol. 2015 Dec;25(12):3438-54
pubmed: 25994193
J Clin Oncol. 2011 May 20;29(15):2011-9
pubmed: 21502544
J Clin Epidemiol. 2008 Apr;61(4):344-9
pubmed: 18313558
Eur Radiol. 2021 Sep;31(9):6489-6499
pubmed: 33447860
Cancers (Basel). 2020 Jul 03;12(7):
pubmed: 32635230
J Vasc Interv Radiol. 2018 Feb;29(2):268-275.e1
pubmed: 29203394
Oncotarget. 2016 Apr 12;7(15):21034-45
pubmed: 26992234
Pathol Res Pract. 2012 Oct 15;208(10):592-7
pubmed: 22898351
Eur Radiol. 2019 May;29(5):2698-2705
pubmed: 30402706
Int J Hyperthermia. 2019;36(1):337-343
pubmed: 30729818
Ann Surg Oncol. 2016 Aug;23(8):2635-43
pubmed: 27016292
J Surg Oncol. 2004 Dec 15;88(4):261-6
pubmed: 15565587
JAMA Oncol. 2017 Feb 1;3(2):211-219
pubmed: 27787550
Oncotarget. 2017 Jun 28;8(59):100791-100800
pubmed: 29246023
Dig Liver Dis. 2018 Oct;50(10):1088-1092
pubmed: 30055964
Arch Surg. 2008 Dec;143(12):1204-12
pubmed: 19075173